Screener
Amneal Pharmaceuticals, Inc. AMRX Intangibles (Net)
Intangibles (Net) at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IntangibleAssetsNetExcludingGoodwill.
The source filing: Amneal Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 5:19 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001723128-26-000031
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Total current assets | 1,947,029 | 1,911,181 |
| Property, plant and equipment, net | 456,877 | 442,950 |
| Goodwill | 593,499 | 595,470 |
| Intangible assets, net | 587,830 | 563,498 |
| Operating lease right-of-use assets | 44,361 | 38,832 |
| Operating lease right-of-use assets - related party | 13,723 | 15,216 |
| Financing lease right-of-use assets | 52,360 | 53,328 |
| Other assets | 80,669 | 57,805 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Amneal Pharmaceuticals, Inc.'s intangibles (net)?
- Amneal Pharmaceuticals, Inc. (AMRX) reported intangibles (net) of $587.83M in Q2 2026.
- How has Amneal Pharmaceuticals, Inc.'s intangibles (net) changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s intangibles (net) decreased by 9.5% year-over-year, from $649.55M to $587.83M.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s intangibles (net)?
- Over 5 years (2020 to 2025), Amneal Pharmaceuticals, Inc.'s intangibles (net) has grown at a -15.5% compound annual growth rate (CAGR), from $1.3B to $563.5M.
- What does intangibles (net) mean?
- Identifiable intangible assets (patents, trademarks, customer relationships, technology) net of accumulated amortization — excluding goodwill.
Ask your AI about Amneal Pharmaceuticals, Inc.'s intangibles (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude